Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
The Pending NDC and Bar Code Rule: Distributor Perspectives
The FDA has proposed an amendment to its regulations to adopt a uniform, 12-digit format for the NDC. In part two of this series, HDA’s Senior Director, Industry Relations, Tim Stearns discusses the NDC and bar code proposed amendments and analyzes distributors' comments.
HDA Convenes Supply Chain Experts and Patient Advocates To Examine Drug Shortages Solutions
HDA recently hosted a LinkedIn Live discussion exploring how supply chain stakeholders are working together to tackle these challenges and advocate for solutions. The event featured perspectives from Laura Bray, Chief Change Maker and Founder of Angels for Change, and April Giles, Executive Director of the End Drug Shortages Alliance (EDSA). Chip Davis, HDA President and Chief Executive Officer, moderated the discussion, which also touched upon effects of recent hurricanes on the prescription supply and the newly announced Biden Cancer Moonshot pilot program to curb pediatric shortages.
Read three takeaways from the conversation.
Value Drug Helps Pharmacies During COVID-19
Every day, pharmacists are on the frontlines of patient care — providing information and resources, valuable face-to-face counseling as well as dispensing the medicines that patients need to manage their health and well-being. During COVID-19, pharmacists’ role as counselors, educators and advocates to patients has never been more critical.
COVID-19 Reinforces KeySource’s Commitment to Helping Those in Need
Since 2006, thousands of uninsured and underinsured patients in Cincinnati, Ohio, and neighboring communities have been able to fill their critically needed medications at no charge through the St. Vincent de Paul Charitable Pharmacy. By filling prescriptions with no out-of-pocket cost for patients, the charitable pharmacy is committed to providing care for individuals who need it most.
How Distributors Are Helping America Get Vaccinated
With the Delta variant surging across the United States, the fight against COVID-19 — and in turn, the most extensive vaccination campaign in our country’s history — is far from over. As the effects of the virus continue to reverberate, the Biden administration recently authorized booster shots, and the Food and Drug Administration granted full approval of the first COVID-19 vaccine in an effort to increase vaccination rates across the U.S.